Ankyrin repeat domain 26 pseudogene 1 (ANKRD26P1)

ANKRD26P1 is a pseudogene—a genomic DNA sequence derived from the protein-coding gene ankyrin repeat domain 26, but rendered nonfunctional by disabling mutations such as frameshifts or premature stop codons[2][4]. Pseudogenes are generally considered genetic "fossils," though a few may act as regulatory elements at the RNA level, but there is no evidence supporting such a role for ANKRD26P1 specifically[2][4]. The gene is catalogued under NCBI Gene ID 124149 and maps to multiple database entries as a nonfunctional pseudogene[1][2]. There is no published evidence of any protein product, drug interactions, role as a biomarker, or relevance as a therapeutic target. As a pseudogene, ANKRD26P1 is considered not a therapeutic target and is generally excluded from protein-centric research and drug discovery pipelines. ANKRD26P1 is a nonfunctional pseudogene, not a bona fide therapeutic target, with no known direct biological role, no drug interactions, and no evidence supporting its utility or risk in clinical or basic research as a target molecule[1][2][4].

Other names

Putative ankyrin repeat domain-containing protein 26-like proteinFLJ43980AR26L_HUMAN